At a Glance
Decheng Capital is a venture capital firm founded in 2012. Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise to build highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital and the support from some of the most prestigious limited partners in the world, Decheng is poised to create value for our investors and entrepreneur partners. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. The firm manages $2B in assets under management.
“Focuses on growth-stage investments in technology, healthcare, and consumer companies across China and Southeast Asia.”
Decheng Capital primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Decheng Capital is headquartered in Shanghai, China. Many of their portfolio companies are also based in this region, though they invest across geographies.
Decheng Capital focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Decheng Capital's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
Decheng Capital manages approximately $2B in assets under management (AUM) across their funds.